Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1948 2
1950 3
1951 3
1952 1
1953 8
1954 5
1955 6
1956 8
1957 6
1958 3
1959 12
1960 1
1961 3
1962 9
1963 7
1964 9
1965 16
1966 27
1967 17
1968 23
1969 24
1970 23
1971 31
1972 32
1973 27
1974 24
1975 36
1976 28
1977 39
1978 42
1979 48
1980 55
1981 50
1982 52
1983 58
1984 70
1985 54
1986 88
1987 108
1988 101
1989 112
1990 110
1991 100
1992 125
1993 118
1994 94
1995 81
1996 99
1997 104
1998 111
1999 123
2000 103
2001 111
2002 126
2003 119
2004 114
2005 123
2006 136
2007 128
2008 129
2009 117
2010 128
2011 147
2012 176
2013 163
2014 175
2015 187
2016 176
2017 183
2018 172
2019 180
2020 206
2021 210
2022 207
2023 181
2024 183
2025 1

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

5,715 results

Results by year

Filters applied: . Clear all
Page 1
Translating IL-6 biology into effective treatments.
Choy EH, De Benedetti F, Takeuchi T, Hashizume M, John MR, Kishimoto T. Choy EH, et al. Among authors: takeuchi t. Nat Rev Rheumatol. 2020 Jun;16(6):335-345. doi: 10.1038/s41584-020-0419-z. Epub 2020 Apr 23. Nat Rev Rheumatol. 2020. PMID: 32327746 Free PMC article. Review.
EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs: 2019 update.
Smolen JS, Landewé RBM, Bijlsma JWJ, Burmester GR, Dougados M, Kerschbaumer A, McInnes IB, Sepriano A, van Vollenhoven RF, de Wit M, Aletaha D, Aringer M, Askling J, Balsa A, Boers M, den Broeder AA, Buch MH, Buttgereit F, Caporali R, Cardiel MH, De Cock D, Codreanu C, Cutolo M, Edwards CJ, van Eijk-Hustings Y, Emery P, Finckh A, Gossec L, Gottenberg JE, Hetland ML, Huizinga TWJ, Koloumas M, Li Z, Mariette X, Müller-Ladner U, Mysler EF, da Silva JAP, Poór G, Pope JE, Rubbert-Roth A, Ruyssen-Witrand A, Saag KG, Strangfeld A, Takeuchi T, Voshaar M, Westhovens R, van der Heijde D. Smolen JS, et al. Among authors: takeuchi t. Ann Rheum Dis. 2020 Jun;79(6):685-699. doi: 10.1136/annrheumdis-2019-216655. Epub 2020 Jan 22. Ann Rheum Dis. 2020. PMID: 31969328 Free article.
Microbial Metabolites and Gut Immunology.
Takeuchi T, Nakanishi Y, Ohno H. Takeuchi T, et al. Annu Rev Immunol. 2024 Jun;42(1):153-178. doi: 10.1146/annurev-immunol-090222-102035. Annu Rev Immunol. 2024. PMID: 38941602 Free article. Review.
Efficacy of synthetic and biological DMARDs: a systematic literature review informing the 2022 update of the EULAR recommendations for the management of rheumatoid arthritis.
Kerschbaumer A, Sepriano A, Bergstra SA, Smolen JS, van der Heijde D, Caporali R, Edwards CJ, Verschueren P, de Souza S, Pope JE, Takeuchi T, Hyrich KL, Winthrop KL, Aletaha D, Stamm TA, Schoones JW, Landewé RBM. Kerschbaumer A, et al. Among authors: takeuchi t. Ann Rheum Dis. 2023 Jan;82(1):95-106. doi: 10.1136/ard-2022-223365. Epub 2022 Nov 11. Ann Rheum Dis. 2023. PMID: 36368906
Consensus statement on blocking interleukin-6 receptor and interleukin-6 in inflammatory conditions: an update.
Aletaha D, Kerschbaumer A, Kastrati K, Dejaco C, Dougados M, McInnes IB, Sattar N, Stamm TA, Takeuchi T, Trauner M, van der Heijde D, Voshaar M, Winthrop KL, Ravelli A, Betteridge N, Burmester GR, Bijlsma JW, Bykerk V, Caporali R, Choy EH, Codreanu C, Combe B, Crow MK, de Wit M, Emery P, Fleischmann RM, Gabay C, Hetland ML, Hyrich KL, Iagnocco A, Isaacs JD, Kremer JM, Mariette X, Merkel PA, Mysler EF, Nash P, Nurmohamed MT, Pavelka K, Poor G, Rubbert-Roth A, Schulze-Koops H, Strangfeld A, Tanaka Y, Smolen JS. Aletaha D, et al. Among authors: takeuchi t. Ann Rheum Dis. 2023 Jun;82(6):773-787. doi: 10.1136/ard-2022-222784. Epub 2022 Aug 11. Ann Rheum Dis. 2023. PMID: 35953263 Free article.
Anti-GM-CSF otilimab versus tofacitinib or placebo in patients with active rheumatoid arthritis and an inadequate response to conventional or biologic DMARDs: two phase 3 randomised trials (contRAst 1 and contRAst 2).
Fleischmann RM, van der Heijde D, Strand V, Atsumi T, McInnes IB, Takeuchi T, Taylor PC, Bracher M, Brooks D, Davies J, Goode C, Gupta A, Mukherjee S, O'Shea C, Saurigny D, Schifano LA, Shelton C, Smith JE, Wang M, Wang R, Watts S, Weinblatt ME. Fleischmann RM, et al. Among authors: takeuchi t. Ann Rheum Dis. 2023 Dec;82(12):1516-1526. doi: 10.1136/ard-2023-224482. Epub 2023 Sep 12. Ann Rheum Dis. 2023. PMID: 37699654 Free PMC article. Clinical Trial.
[Rheumatoid arthritis].
Kameda H, Takeuchi T. Kameda H, et al. Among authors: takeuchi t. Nihon Rinsho. 2009 Mar;67(3):495-9. Nihon Rinsho. 2009. PMID: 19280922 Review. Japanese.
Anti-human-TIGIT agonistic antibody ameliorates autoimmune diseases by inhibiting Tfh and Tph cells and enhancing Treg cells.
Kojima M, Suzuki K, Takeshita M, Ohyagi M, Iizuka M, Yamane H, Koga K, Kouro T, Kassai Y, Yoshihara T, Adachi R, Hashikami K, Ota Y, Yoshimoto K, Kaneko Y, Morita R, Yoshimura A, Takeuchi T. Kojima M, et al. Among authors: takeuchi t. Commun Biol. 2023 May 9;6(1):500. doi: 10.1038/s42003-023-04874-3. Commun Biol. 2023. PMID: 37161050 Free PMC article.
5,715 results